Skip to main content

NeuroMind AGI

The AI Platform for Cognitive Defense

Every critical system is monitored in real time. The human operator is not.

Objective neurofunctional monitoring for Cognitive Warfare and Human Performance Optimization (HPO).

Defense · Aerospace · Cyber Operations · Healthcare

Deep TechDual-UseSeed StageTRL 5Patent FiledPre-MDR

The Mind Is the Last Unmonitored System

Questionnaires are gameable. Wearables measure proxies. Standard clinical tests miss what matters most.

What Exists

Wearables tracking heart rate, sleep, movement. Questionnaires. Neuropsychological tests. Clinical interviews.

Why It's Not Enough

Self-reported data is gameable. Wearables measure physiological proxies — not actual cognitive function. Standard tools miss compensated dysfunction.

What's Missing

An objective, explainable, regulation-aligned system that reads neurofunctional state directly from brain activity — and translates it into an operational decision.

No player owns this layer. NeuroMind AGI does.

NeuroMind: The AI Platform for Cognitive Defense and Human Performance Optimization

Software-only. No hardware. No devices. Runs on any certified third-party EEG headset.

The software intelligence layer between raw brain activity and an operational decision — objective, explainable, designed for regulated environments.

Proprietary neurofunctional pipeline processes EEG signals and extracts objective indicators of cognitive state — attention, fatigue, overload, degraded decision capacity.

AI operates at the inference layer — supervised ML models classify neurofunctional indicators derived from ERP-based EEG protocols. Expert logic ensures interpretability.

Every AI-generated output is reviewed by a human specialist, enabling function as a decision-support system in regulated environments.

Peer-Reviewed. 95% Accuracy.

95% classification accuracy — including cognitive profiles invisible to every standard clinical tool. (Marconi · Pessa · Penna — IEEE MEMEA 2018)

27 subjects assessed with full clinical tools. Conventional tools identified two groups. Neurophysiological analysis revealed three — including masked subjects showing objective impairment detectable only through ERP-based EEG indicators.

Standard tools: Questionnaires 70% · Clinical rating scales 80% · Neuropsychology 60% · EEG neurofunctional method: 95%. The breakthrough comes from the neurophysiological method — not from data volume. Patent filed January 2026.

The pilot who passes standard screening. The cyber analyst within range on every questionnaire. The surgeon with no red flags. NeuroMind detects what standard tools cannot see.

A Single Neurofunctional Assessment Platform

Deployed across defense, cyber, aerospace, enterprise leadership, and healthcare environments.

Platform Architecture

Standardized neurofunctional assessment engine generating objective cognitive performance indicators

Explainable AI models translating neurofunctional signals into operationally relevant metrics

Modular interpretation layer adapted to mission context and operational domain

Operational Domains

Defense operations — pilots, drone operators, naval crews, special forces

Cyber operations — SOC analysts and cyber defense teams

Space operations — satellite mission control operators

Enterprise leadership — executives and critical decision roles

Healthcare diagnostics — psychiatry and neurocognitive evaluation

Built for Regulated, Enterprise-Scale Deployment

The operational, financial, legal, and clinical execution team.

C-Suite

Massimiliano Gattoni

Massimiliano Gattoni

Cav. Ing.
Chief Executive Officer

25 years in digital transformation, AI, strategic innovation. Former executive at Microsoft, Open Fiber, FS. One of 17 global Digital Transformation SMEs (Microsoft). Advisor in two Italian governments. Knight of the Order of Merit (2021).

Pierluigi Marconi

Pierluigi Marconi

Prof.
Chief Scientific Officer

34 years in medicine, psychiatry, neuroscience. Pioneer in AI diagnostics and EEG analysis. Lead author IEEE MEMEA 2018. Professor, Sapienza University. Founder, Artemis Neurosciences.

Rosamaria Scognamiglio

Rosamaria Scognamiglio

Chief Clinical & Research Officer

20 years in clinical research. Designs and oversees clinical trials and hospital partnerships. Manages national and EU-funded research programs.

Stefano Capponi

Stefano Capponi

Chief Financial Officer

25 years in finance and corporate governance. Former Director AIFA (2006–2014). EMA/AIFA regulatory expertise. Court-Appointed Technical Consultant.

Valentina Gnoatto

Valentina Gnoatto

Chief Legal Officer

10 years in corporate governance and regulatory compliance. Former legal advisor, Italian Senate Health Committee. Healthcare law and EU compliance expert.

Contact Us

NeuroMind AGI S.r.l.
Viale Cesare Pavese 163, 00144 Roma
P.IVA IT17611671003
DUNS
442036996
REA
RM-1729743
VAT
IT17611671003